Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Analabs Resources Bhd's revenue for the
three
months ended in Apr. 2026 was RM46.6 Mil.
Its revenue for the trailing twelve months (TTM) ended in Apr. 2026 was RM127.6 Mil.
Analabs Resources Bhd's Revenue per Share for the
three
months ended in Apr. 2026 was RM0.41.
Its Revenue per Share for the trailing twelve months (TTM) ended in Apr. 2026 was RM1.14.
Warning Sign:
Analabs Resources Bhd revenue per share has been in decline over the past 3 years.
During the past 12 months, the average Revenue per Share Growth Rate of Analabs Resources Bhd was -8.20% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -1.60% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 3.00% per year.
During the past 10 years, the average Revenue per Share Growth Rate was -0.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, Analabs Resources Bhd's highest 3-Year average Revenue per Share Growth Rate was 48.40% per year. The lowest was -8.60% per year. And the median was 4.50% per year.
Analabs Resources Bhd (XKLS:7083) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, Analabs Resources Bhd's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Analabs Resources Bhd Revenue vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Analabs Resources Bhd's Revenue distribution charts can be found below:
* The bar in red indicates where Analabs Resources Bhd's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM127.6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Analabs Resources Bhd (XKLS:7083) has a Revenue of RM127.6 Mil as of Apr. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Analabs Resources Bhd and its competitors.
Is Analabs Resources Bhd's Revenue too high?
Analabs Resources Bhd's current Revenue is RM127.6 Mil. Overall, Analabs Resources Bhd has a GF Score™ of 68/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Analabs Resources Bhd's Revenue compare to LIN and SHW?
Analabs Resources Bhd's Revenue of RM127.6 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Chemicals company?
A good Revenue depends on the Chemicals industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Analabs Resources Bhd and its competitors. Analabs Resources Bhd's current Revenue is RM127.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Analabs Resources Bhd stock overvalued right now?
Based on GuruFocus' analysis, Analabs Resources Bhd (XKLS:7083) is currently considered Modestly Overvalued. The stock's GF Value™ is RM1.53, compared to a current price of RM1.76 — trading 15% above its estimated fair value. The current Revenue is RM127.6 Mil. Analabs Resources Bhd's overall GF Score™ is 68/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Analabs Resources Bhd (XKLS:7083), the current Revenue is RM127.6 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Analabs Resources Bhd (XKLS:7083) Overvalued in 2026?
Based on GuruFocus' analysis, Analabs Resources Bhd stock appears to be overvalued.
The current stock price of RM1.76 is trading 15% above its estimated GF Value™ of RM1.53.
GuruFocus considers Analabs Resources Bhd to be Modestly Overvalued.
Key valuation signals for XKLS:7083:
Revenue: RM127.6 Mil
GF Value™: RM1.53 vs. price of RM1.76 (15% above fair value)
No single metric tells the full story. See the XKLS:7083 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Analabs Resources Bhd is a Malaysia-based company engaged in the businesses of investment holding and the provision of management services. It has five business segments, which include: Manufacturing, formulation, and sale of resin, chemicals, and building materials; Recovery and sale of recycled products; Contract work, pipe laying, and rehabilitation; Culture and sale of prawns; Investment holding and property letting, and asset and portfolio management. The company earns the majority of its revenue from the manufacturing, formulation, and sale of resin, chemicals, and building materials. Geographically, the company derives its maximum revenue from Malaysia and the rest from Singapore.
68GF Score
Get the complete analysis for XKLS:7083
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7083 has been successfully added to your 
